DDS development for drug life cycle management
-
- Kikuchi Hiroshi
- DDS Research, Formulation Research Laboratories, Eisai Co., Ltd.
-
- Ishihara Hiroshi
- DDS Research, Formulation Research Laboratories, Eisai Co., Ltd.
-
- Suzuki Takuya
- DDS Research, Formulation Research Laboratories, Eisai Co., Ltd.
Bibliographic Information
- Other Title
-
- 2010年問題の解決策を考える 医薬品のライフサイクルマネジメントとDDS開発
- 医薬品のライフサイクルマネジメントとDDS開発
- イヤクヒン ノ ライフサイクル マネジメント ト DDS カイハツ
Search this article
Abstract
The keyword, life cycle management(LCM)of medicines has recently attracted attention, because the patents of many blockbuster drugs will expire or have expired around 2010. There are many strategies for LCM, and drug delivery system(DDS)is one of the useful approaches. But, it seemed that the development of DDS medicines in Japan was a little bit difficult compared to that in US or Europe. There were many factors such as drug price system, safety tests of new additives, etc. The circumstances for DDS development in Japan have recently become much better through the political efforts of Japanese government.
Journal
-
- Drug Delivery System
-
Drug Delivery System 26 (2), 99-105, 2011
THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679618241664
-
- NII Article ID
- 10027990770
-
- NII Book ID
- AN10084591
-
- ISSN
- 18812732
- 09135006
-
- NDL BIB ID
- 11079458
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed